.
Feedback

Rare Study Session to Focus on Luring Businesses

Development is crucial to Pacifica's long-term economic sustainability, mayor pro tem says. Meeting is first of its kind in over five years.

Pacifica city councilmembers will host a rare public study session on Sunday focusing on bringing some life to a static business environment, Mayor Pro Tem Len Stone told Patch.

The first such meeting in at least five years is being held at the urging of Stone, who wants the city to take a more aggressive stance in attracting businesses. Stone said economic development would generate revenues needed to maintain economic sustainability.

The meeting will be held at the Pacifica Police Department's EOC Room from 9:15 a.m. to 3:30 p.m.

One of Stone's priorities is hiring an economic development director that would spearhead such efforts.

Stone cited efforts in other Peninsula cities, such as San Mateo, San Carlos and Redwood City, where economic development has helped boost revenues.

"We've never as a city set aside money for proactive economic development," he said. "That's something that has to happen."

How the city would fund such efforts, however, isn't clear.

Pacifica erased a structural deficit that all but obliterated city's reserves through a combination of tax increases and job cuts, Stone said, noting the council recently approved an approximately $27 million budget with an estimated $200,000 surplus.

The city's reserves are down to $600,000 from well over $6 million as recently as five or six years ago. Stone said.

The city is exploring police outsourcing as a way to fund discretionary programs such as economic development, Stone said.

A consultant the city commissioned to crunch the numbers reported back to the council earlier this month, however councilmembers have been mum on what, if anything, they gleaned from the consultant's findings.

Patch cited a source with requesting anonymity in a report earlier this year estimating an annual savings to the city of $2 million.  

"If we're going to make progress we're going to have to take capital and spend it on things that are going to increase our revenue in the long term, and that money's going to have to come from somewhere," Stone said. "Something's got to give."

Follow us on Twitter | Like us on Facebook |Sign up for our daily newsletter Blog for us

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Hnin May 24, 2013 at 06:31 pm
Please help share it on your facebook as well. Anything to find our cat.Read More http://sfbay.craigslist.org/pen/laf/3825190526.html
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.